EVE eve health group limited.

high risk no reward .....lose everything......read the headline...

  1. 13,347 Posts.
    lightbulb Created with Sketch. 783
    high risk no reward .....lose everything......
    read the headline from the announcement ...
    Nextract’s alcohol-free, orally dissolvable strips offer near-term path to revenue, targeting
    Australian and MENA markets — $1,000,000 placement secured to expedite clinical
    development and regulatory approval process


    Nextract’s alcohol-free, orally dissolvable strips offer near-term path to revenue, targeting
    Australian and MENA markets
    $1,000,000 placement secured to expedite clinical
    development
    and regulatory approval process

    near term path to revenue .....so no revenue will be received from day dot.....we have to spend money to bring to market.

    targeting australian and middle eastern countries ...you have to do clinical trials before you can sell to either markets ....

    i million placement to secure to expedite clinical development ........to set up a proper lab would cost u more than a million ..

    and regulatory approval process ...well if any one here has bought into pharma before this usually takes more than 3 years,
    and a whole lot of money ......

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.5¢
Change
0.000(0.00%)
Mkt cap ! $8.585M
Open High Low Value Volume
3.5¢ 3.6¢ 3.5¢ $63.64K 1.793M

Buyers (Bids)

No. Vol. Price($)
1 187500 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 92845 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
EVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.